Monograph
M01AC06 - Meloxicam |
Propably not porphyrinogenic |
PNP |
Rationale
Substrate for CYP 2C9 and 3A4. One list consider it probably safe.
Chemical description
Tabl, supp, 7-15 mg/d. Analgetic, antipyretic och anti-inflammatory inhibitor of prostaglandin synthesis used in osteoarthrosis. Oxicam derivative, extensively metabolized by hydroxylation by CYP 2C9 (major reaction) and 3A4 (minor reaction). Inhibitor of CYP 2C9. South African list: use with care
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Meloxicam 
Meloxicam · Mobic 
Meloxicam · Melozaltan · Movalis 
Meloxicam · Mobic · Mobic 7,5 
Melox · Meloxicam · Movalis 
Meloxicam · Mobic 
Duplicam · Meloxicam 
Meloxicam 
Aglan · Aspicam · Aspicam Bio · Difortan · Mel · Melobax · Meloksam · Meloxicam · MeloxiMed Forte · Meloxistad · Moilec · Movalis · Movatec · Opokan · Opokan-forte · Remolexam · Trosicam 
Meloxicam · Mobic 
Mobic 
Melox · Mexolan · Movalis · Recoxa 
Meloksikam · Melox · Movalis
© NAPOS 2025